ÃÛÌÒ´«Ã½

Good morning, investor! In preparation for another busy day of trading, we’ve put together a list of the biggest pre-market stock movers for Thursday!

Source: ventdusud / Shutterstock.com

We’ve got earnings reports, a clinical trial, acquisition news, and more moving stocks this morning.

Let’s dive into that news below!

Pre-ÃÛÌÒ´«Ã½ Stock Movers: 10 Top Gainers

1. Kiromic BioPharma (NASDAQ:KRBP) stock is soaring more than 38% alongside heavy trading this morning.
2. DBV Technologies (NASDAQ:DBVT) shares are gaining over 36% .
3. Aptose Biosciences (NASDAQ:APTO) stock is rising close to 23% despite a lack of news this morning.
4. Samsara (NYSE:IOT) shares are increasing more than 19% .
5. Wheeler Real Estate IT (NASDAQ:WHLR) stock is climbing over 19% .
6. Indonesia Energy Corp (NYSEAMERICAN:INDO) shares are surging almost 19% .
7. Guardion Health Sciences (NASDAQ:GHSI) stock is jumping more than 18% after shares dropped on heavy trading yesterday.
8. Canaan (NASDAQ:CAN) shares are running over 15% higher .
9. Cedar Realty Trust (NYSE:CDR) stock is getting a more than 13% boost .
10. Puhui Wealth Investment (NASDAQ:PHCF) stock is up over 12% on no clear news this morning.

10 Top Losers

1. NuCana (NASDAQ:NCNA) shares are plummeting more than 53% .
2. Weave Communications (NYSE:WEAV) stock is falling over 26% .
3. Snowflake (NYSE:SNOW) shares are diving more than 22% .
4. Rush Street Interactive (NYSE:RSI) stock is tumbling over 14% .
5. MediWound (NASDAQ:MDWD) shares are decreasing more than 14% .
6. Veeva Systems (NYSE:VEEV) stock is declining over 12% .
7. Trevi Therapeutics (NASDAQ:TRVI) shares are heading more than 12% lower after a 32% rally on Wednesday.
8. LSB Industries (NYSE:LXU) stock is slipping over 10% on no apparent news this morning.
9. Kiora Pharmaceuticals (NASDAQ:KPRX) shares are dipping more than 9% after rising higher throughout the week.
10. CNS Pharmaceuticals (NASDAQ:CNSP) stock closes out our pre-market stock movers down over 9% .

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.